Leila Takahashi-Ruiz

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 5

Top Topics

Metastatic Breast Cancer

Mitochondrial Dna

Top Venues

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson, Peter Y W Chan, Susan L Mooberry, April L Risinger
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers 14 (23) (2022)
Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson, Peter Y W Chan, Susan L Mooberry, April L Risinger
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers 14 (23) (2022)
Leila Takahashi-Ruiz, Joseph D Morris, Phillip Crews, Tyler A Johnson, April L Risinger
In Vivo Evaluation of (-)-Zampanolide Demonstrates Potent and Persistent Antitumor Efficacy When Targeted to the Tumor Site. Molecules (Basel, Switzerland) 27 (13) (2022)
Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson, Peter Y W Chan, Susan L Mooberry, April L Risinger
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers 14 (23) (2022)
Leila Takahashi-Ruiz, Charles S Fermaintt, Nancy J Wilkinson, Peter Y W Chan, Susan L Mooberry, April L Risinger
The Microtubule Destabilizer Eribulin Synergizes with STING Agonists to Promote Antitumor Efficacy in Triple-Negative Breast Cancer Models. Cancers 14 (23) (2022)